Background: Clinical manifestations and optimal management strategies in patients with splanchnic vein thrombosis (SVT) are not well characterized.
Methods: We conducted a retrospective cohort study including all newly diagnosed SVT evaluated between January 2007 and December 2018. Efficacy outcome was thrombosis resolution, and safety outcomes included death and occurrence of bleeding.